Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion type Assertion NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_head.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion wasGeneratedBy ECO_0000203 NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_provenance.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion wasDerivedFrom befree-2016 NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_provenance.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion SIO_000772 21224376 NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_provenance.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion evidence source_evidence_literature NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_provenance.
- NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_assertion description "[Sorafenib, a multikinase inhibitor targeting Raf and VEGFR, has shown activity in unselected patients with non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864636.RACOqXWwjiAy-KT5nrc6-tJqy3uqT2Q-yGdw60x_XrElI130_provenance.